Preoperative CYFRA 21-1 Level as a Prognostic Indicator in Lung Cancer
Author Information
Author(s): J Niklinskil, M Furman, T Burzykowski, L Chyczewski, J Laudanskil, E Chyczewska, M Rapellino
Primary Institution: Bialystok Medical Academy, Bialystok, Poland
Hypothesis
Is elevated preoperative CYFRA 21-1 level prognostically significant in patients with resected primary squamous-cell lung cancer?
Conclusion
Elevated preoperative CYFRA 21-1 levels may indicate a higher risk of treatment failure and poor survival in patients with squamous-cell lung cancer.
Supporting Evidence
- 55% of patients had elevated CYFRA 21-1 levels.
- Elevated levels were significantly associated with poor overall survival.
- Multivariate analysis confirmed elevated levels were linked to poor survival outcomes.
Takeaway
Doctors can use a blood test called CYFRA 21-1 to help predict how well patients with lung cancer will do after surgery.
Methodology
Serum levels of CYFRA 21-1 were measured in 91 patients using an immunoradiometric assay, and survival analyses were conducted using Kaplan-Meier and log-rank tests.
Limitations
The study did not include patients who underwent chemotherapy or radiation therapy before surgery.
Participant Demographics
Patients were diagnosed with squamous-cell lung cancer and had a good performance status at the time of surgery.
Statistical Information
P-Value
P=0.0001 for TNM stage, P<0.00005 for overall survival and disease-free survival in univariate analysis.
Confidence Interval
95% CI for overall survival was 0.346-0.638.
Statistical Significance
p<0.00005
Want to read the original?
Access the complete publication on the publisher's website